Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Child's Nervous System
Erschienen in: Child's Nervous System 4/2017

26.09.2016 | Cover Editorial

Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms

verfasst von: Martino Ruggieri, Andrea D. Praticò, Agostino Serra, Luigi Maiolino, Salvatore Cocuzza, Rosario Caltabiano, Agata Polizzi

Erschienen in: Child's Nervous System | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Excerpt

As in many diseases, exactly which was the first case report of “neurofibromatosis” and who truly deserves the eponymous for credit have been a matter of debate [6, 42, 66]. Certainly, in the past centuries, several renowned “patients” taken from fiction or reality have been labelled as having this condition and, among all, Joseph Merrick also known as the “elephant man” [11, 41, 77, 87] and Quasimodo the “hunchback” of “Notre Dame de Paris” by Victor Hugo [12, 76] are two infamous examples who played an important role in the distorted popular misconception of the disease. The history of neurofibromatosis (in this case neurofibromatosis type 1—NF1), in fact, can be traced to ancient times, if descriptions of grotesque or distorted persons are considered [1, 6, 37, 42, 51, 54, 100]. …
Literatur
1.
Ahn MS, Jackler RK, Lustig LR (1996) The early history of the neurofibromatoses. Evolution of the concept of neurofibromatosis type 2. Arch Otolaryngol Head Neck 122:1240–1249CrossRef
2.
Antoni NR, Bergmann JF (1920) Uber Ruckenmarksteumoren und Neurofibrome
3.
Ashrafian H (2011) Limb gigantism, neurofibromatosis and royal heredity in the Ancient World 2500 years ago: Achaemenids and Parthians. J Plast Reconstr Aesthet Surg 64:557CrossRefPubMed
4.
Baser ME, Friedman JM, Evans DG (2006) Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology 66:730–732CrossRefPubMed
5.
Biggs GN (1909) A case of multiple intracranial tumours with involvement of both auditory nerves. Lancet 2:14–15CrossRef
6.
7.
Burger PC, Scheithauer BW, Vogel FS (2002) Surgical pathology of the nervous system and its coverings, 4th edn. Churchill Livingstone, London, p. 595
8.
Caprotti E (1980) Mostri, Draghi e Serpenti nelle Silografie di Ulisse Aldrovandi e dei suoi Contemporanei. Mazzotta editore, Milano
9.
Cohen MM Jr (1988) Invited historical comment: further diagnostic thought about the elephant man. Am J Med Genet 29:777–782CrossRefPubMed
10.
Cohen MM Jr (1986) The elephant man did not have neurofibromatosis. Proc Greenwood Genet Ctr 6:187–192
11.
Cohen MM Jr (1988) Understanding Proteus syndrome, unmasking the elephant man, and stemming elephant fever. Neurofibromatosis 1:260–280PubMed
12.
Cox J (1985) Quest for Quasimodo (V. Hugo. Br Med J (Clin Res Ed) 291:1801–1803CrossRef
13.
Crowe FW, Schull WJ, Neel JV (1956) A clinical, pathological and genetic study of mutliple neurofibromatosis. Charles C. Thomas, Springfield
14.
Crump T (1981) Translation of case reports in Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen by F. v. Recklinghausen. Adv Neurol 29:259–275PubMed
15.
Cruveilhier J (1835–1842) Anatomie pathologique du corps humain, ou descriptions, avec figures lithographiees et coloriees, des diverses alterations morbides dont le corps humain est susceptible. Paris, France: Bailliere 2:1–8
16.
Cushing H, Eisenhardt L (1938) Meningiomas. Their classification, regional behaviour, life history, and surgical end results. Springfield, IL, and Baltimore
17.
Cushing H (1917) Tumors of the nervus acusticus and the syndrome of the cerebello-pontine angle. W.B. Saunders, Philadelphia
18.
Dandy WE (1925) An operation for the total removal of cerebellopontile (acoustic) tumors. Surg Gynecol Obstet 16:2 129–148
19.
20.
21.
Fahlgren AH, Muller R (1955) Familjar forekomst av bilateral akustikustumor. Nord Med 257–259
22.
Feeling A, Ward E (1920) A familial form of acoustic tumour. BMJ 1:496–497CrossRef
23.
Foster WD (1961) A short history of clinical pathology. E Livingstone Ltd, Edinburgh, p. 15
24.
Fraenkel J, Hunt JR (1903) On neurofibromatosis. Med Rec 63:925–932
25.
Friedrich V, Peda G (1998) Waldassen Foundation library (Waldsassen Stiftsbibliothek). Kunstverlag, Passau
26.
Fulton JF, Robert W (1929) Smith’s description of generalised neurofibromatosis. N Engl J Med 200:1315–1317CrossRef
27.
Funkestein O (1905) Ein Beitrag zur Kenntnis der Tumoren des Kleinhirnbruckenwinkels (‘zentrale Neurofibromatose,’ ‘Akustikusneurome. Mitt Grenzgeb Med Chir 14:157–194
28.
Gardiner WT, Frazier CH (1930) Bilateral acoustic neurofibromas: a clinical study and field survey of a family of five generations with bilateral deafness in 38 members. Arch Neurol Psych 23:266–300CrossRef
29.
Gardner WJ, Turner O (1940) Bilateral acoustic neurofibromas: further clinical and pathological data on hereditary deafness and Reckinglhausen’s disase. Arch Neuropsych 44:76–99CrossRef
30.
Gardner WJ, Turner O (1931) Hereditary bilateral acustic tumors. J Hered 22:7–8CrossRef
31.
Gibson GA (1895) Remarks on the results of surgical measures in a series of cerebral cases, III: cerebellar tumour. Edin Med J 41:689–692
32.
Giudetti B (1952) Neurofibromi bilaterali dell’acustico. Riv Pat Nerv Ment 73:433–338
33.
34.
Happle R (1997) A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 133:1505–1509CrossRefPubMed
35.
Happle R (2014) Mosaicism in human skin. Understanding nevi, nevoid skin disorders, and cutaneous neoplasia. Berlin/Heidelberg: Springer-Verlag, pp. 13–37; 45–61; 63–65
36.
Happle R (1996) Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet 66:241–242CrossRefPubMed
37.
Hecht F (1989) Recognition of neurofibromatosis before von Recklinghausen. Neurofibromatosis 2:180–184PubMed
38.
Henneberg B, Koch M (1903) Uber centrale Neurofibromatose und die Geschwälste des Kleinhirnbrückenwinkels (Acusticusneurome). Arch Psychiat 36:251–304CrossRef
39.
Henschen F (1915) Zur histologie und pathogenese der Kleinhirnbruckenwinkel tumoren. Arch F Psychiatr 36:251
40.
House WF (1989) Acoustic tumor surgery: an historical perspective. Semin Hearing 10:293–305
41.
Howell M, Ford P (1983) The true history of the elephant man. A new edition of the story of Joseph Carey Merrick whose tragic life and extraordinary fate are told in this book. London: penuin Books Ltd.
42.
Huson SM, Hughes RAC (1994) The neurofibromatoses: pathogenetic and clinical overview. Chapman & Hall, London
43.
Kanter WR, Eldridge R, Fabricant R, et al. (1980) Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology 30:851–859CrossRefPubMed
44.
Kleihues P, Cavenee WK (2000) Pathology and genetics. Tumours of the nervous system. Lyon: IARCPress
45.
Knoblauch, J (1843) De neuromate et gangliis accessories. Frankfurt, Dissertation
46.
47.
Lyons JB, Staunton H (1992) Neurofibromatosis: why not Smith’s disease? J Hist Neurosci 1:65–73CrossRefPubMed
48.
Madigan P, Masello MJ (1989) Report on a neurofibromatosis-like case: monstruorum historia, 1642. Neurofibromatosis 2:53–56PubMed
49.
Malkin HM (1993) Out of the mist: the foundation of modern pathology and medicine in the nineteenth century. Vesalius Books, Berkeley, p. 327
50.
Masson P (1932) Experimental and spontaneous schwannomas (peripheral gliomas): I. Experimental schwannomas. Am J Pathol 8:367–388.1PubMedPubMedCentral
51.
52.
Mossé A, Cavalié (1897) Tumeurs multiples de l’encephale et de la moelle allongée: neurofibromatose centrale. Gaz Hebd Med Chir 2:789
53.
Moyes PD (1968) Familial bilateral acoustic neuroma affecting 14 members from four generations. J Neurosur 29:78–82CrossRef
54.
Mulvhill JJ (1988) Neurofibromatosis: history, nemenclature and natural history. Neurofibromatosis 1:124–131
55.
Pavone P, Pettoello-Mantovano M, Le Pira A, et al (2010). Acute disseminated encephalomyelitis. A long-term prospective study and meta-analysis. Neuropediatrics 41:246–55
56.
Pavone P, Spalice P, Polizzi A, Parisi P, Ruggieri M (2012) Ohtahara syndrome with emphasis on recent genetic discovery. Barin Dev 34:459–468CrossRef
57.
Pavone P, Striano P, Falsaperla R, Pavone L, Ruggieri M (2014) Infantile spasms syndrome, west syndrome and related phenotypes: what we know in 2014? Brain and Development 36:739–751CrossRefPubMed
58.
Penfield W (1927) On the nature of neuromas. Surg Gynec Obstet 45:178
59.
Plotkin SR, Blakeley JO, Evans DG, et al. (2013) Update from the 2011 International Schwannomatosis Workshop: from genetics to diagnostic criteria. Am J Med Genet A 161A:405–416CrossRefPubMed
60.
61.
Riccardi VM, Koehler PJ (2000) Von Recklinghausen disease. In: Koehler PJ et al. (eds) Neurological eponyms. Oxford University Press, Oxford, pp. 357–365
62.
Ruggieri M, Mc Shane MA (1998) Parental view of epilepsy in Angelman syndrome: a questionnaire study. Arch Dis Child 79:423–426
63.
Ruggieri M, Gabriele AL, Polizzi A, et al. (2013) Natural history of neurofibromatosis type 2 with onset before the age of 1 year. Neurogenetics 14:89–98CrossRefPubMed
64.
Ruggieri M, Huson SM (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433–1443CrossRefPubMed
65.
Ruggieri M, Iannetti P, Polizzi A, et al. (2005) Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics 36:21–34CrossRefPubMed
66.
Ruggieri M, Polizzi A (2003) From Aldrovandi’s homuncio (1592) to Buffon’s girl (1749) and the wart man of Tilesisus (1793): antique illustrations of mosaicism in neurofibromatosis? J Med Genet 40:227–232CrossRefPubMedPubMedCentral
67.
Ruggieri M, Polizzi A (2000) Segmental neurofibromatosis. J Neurosurg 93:530–532PubMed
68.
Ruggieri M, Pavone P, Polizzi A, et al. (2004) Ophthalmogical manifestations in segmental (localised) neurofibromatosis type 1. Br J Ophthalmol 88:1429–1433CrossRefPubMedPubMedCentral
69.
Ruggieri M, Praticò AD, Evans DG (2015) Diagnosis, management and new therapeutic options in childhood neurofibromatosis type 2 (NF2) and related disorders. Semin Pediatr Neurol 22:240–258CrossRefPubMed
70.
Ruggieri M, Praticò AD (2015) Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol 22:207–233CrossRefPubMed
71.
Ruggieri M (2001) Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2)—no longer neurofibromatosis type 5. Am J Med Genet 101:178–180CrossRefPubMed
72.
Sanchez GM, Siuda T (2002) Ebers Papyrus case #873: a probable case of neurofibromatosis 1. S D J Med 55:529–535PubMed
73.
Sandifort E (1777) Observationes anatomico-patologicae. Leiden, the Netherlands: vd Eyeck P, Vygh D, Lugduni-Batavorum 116–120
74.
Schieppati A, Enter JI, Daina E, et al. (2008) Why rare diseases are an important medical and social issue. Lancet 371:2039–2041CrossRefPubMed
75.
Selwood D (1971) An introduction to the coinage of Parthia. London Spink
76.
77.
Seward GR (1994) Did the elephant man have neurofibromatosis type 1? In: Huson SM, Hughes RAC (eds) The neurofibromatoses. A pathogenic and clinical overview, Chapman & Hall Medical, London, pp. 382–401
78.
Shah HM, Chung KC (2008) Robert William Smith: his life and his contributions to medicine. J Hand Surg 33A:948–951CrossRef
79.
Simili R (2001) Il Teatro della Natura di Ulisse Aldrovandi. Bologna: Editrice Compositori
80.
Smith MJ, Kulkarni A, Rustad C, et al. (2012) Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis. Am J Med Genet A 158A:215–219CrossRefPubMed
81.
Smith RW (1847) A treatise on fractures in the vicinity of joints and on certain forms of accidental and congenital dislocations. Hodges and Smith, Dublin, pp. 6–164
82.
Smith RW (1849) A treatise on the pathology, diagnosis and treatment of neurofibroma. Hodges & Smith, Dublin
83.
Sonig A, Gandhl V, Nanda A (2014) From the cell of Schwann to schwannoma: a century’s fruition. World Neurosurg 82:906–911CrossRefPubMed
84.
Sternberg C (1900) Beitrag zur Kenntniss der sogenannten Geschwulste des Nervus acusticus. Z Heilkd 21:163–186
85.
Tega W (2002) Ulisse Aldrovandi Museum. In Tega W (ed.): Guide to Palazzo Poggi Museum. Science and Art. Bologna: Editrice Compositori, pp. 20–25
86.
Thomson A (1900) On neuroma and neurofibromatosis. Turnbull & Spears, Edinburgh, pp. 7–10
87.
Tibbles JAR, Cohen MM (1986) The Proteus syndrome: the elephant man diagnosed. Br Med J 293:683–685CrossRef
88.
Tilesius von Tilenau WG (1793) Historia pathologica singularis Cutis Turpitudinis: Jo Gondofredi Rheinardi viri Lannorum. Leipzig: Germanny, SL Crusius
89.
Todman D (2008) Warts and the kings of Parthia: an ancient representation of hereditary neurofibromatosis depicted in coins. J Hist Neurosci 17:141–146CrossRefPubMed
90.
Treves F (1885) A case of congenital deformity. Trans Pathol Soc Lond 36:494–498
91.
Treves F (1885) Congenital deformity, in Reports of Societies Pathological of London, Br Med J 1885; 1:595–596
92.
Treves F (1923) The elephant man and other reminiscences. Cassell, London
93.
94.
Unsigned comment (1890) Death of the elephant man. Br Med J 916–917
95.
Von Recklinghausen FD (1882) Uber ide multiplen Fibrome der Haut und ihre beziehung zu den multiplen Neuromen. Berlin: Hirschwald 3–18
96.
Wilkins R, Brody IA (1971) Von Recklinghausen’s neurofibromatosis. Arch Neurol 24:374–375CrossRefPubMed
97.
Wishart J (1822) Cases of tumours in the skull, dura mater and brain. Edinb Med Surg J 18:393–397
98.
Worster-Drought C, Dickson WEC, McMenemey WH (1937) Multiple meningeal and perineural tumors with analogous changes in the glia and ependyma (neurofibroblastomatosis). Brain 60:85–117CrossRef
99.
Young DF, Eldridge R, Gardner WJ (1970) Bilateral acoustic neuroma in a large kindred. JAMA 214:347–353CrossRefPubMed
100.
Zanca A, Zanca A (1980) Antique illustrations of neurofibromatosis. Int J Dermatol 9:55–58CrossRef
101.
Zanca A, Zanca A (1977) Iconografia dermatologica del passatro. Antiche illustrazioni di neurofibromatosi multipla. Chron Dermatol 2:283–287
Metadaten
Titel
Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms
verfasst von
Martino Ruggieri
Andrea D. Praticò
Agostino Serra
Luigi Maiolino
Salvatore Cocuzza
Rosario Caltabiano
Agata Polizzi
Publikationsdatum
26.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 4/2017
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-016-3226-8

Weitere Artikel der Ausgabe 4/2017

Child's Nervous System 4/2017 Zur Ausgabe

Case Report

Traumatic intracranial displacement of the ventriculoperitoneal valve chamber in a child—a report of 2 cases

Case Report

Optimal pediatric dosing of anti-platelet agents for pipeline stent embolization —a case report and review of the literature

Original Paper

Positional plagiocephaly is associated with sternocleidomastoid muscle activation in healthy term infants

Original Paper

Children presenting in delayed fashion after minor head trauma with scalp swelling: do they require further workup?

Original Paper

A comparison of clinicopathological features and surgical outcomes between pediatric skull base and non-skull base meningiomas

Abstracts

XII Brazilian Congress of Pediatric Neurosurgery

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.